BridgeMD
New treatment option for Postoperative Pain
Official title Bupivacaine for Postoperative Pain After Laparoscopic Hysterectomy
ClinicalTrials.gov ID: NCT07435909
What this study is testing
What is Bupivacaine %0.5 (hyperbaric)?
Bupivacaine %0.5 (hyperbaric) is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for postoperative pain.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This prospective, randomized, single-blind controlled study aims to evaluate the effect of bupivacaine injection at trocar entry sites and the vaginal cuff on postoperative pain in patients undergoing total laparoscopic hysterectomy for benign gynecologic conditions. Postoperative pain after laparoscopic hysterectomy may arise from trocar insertion sites and surgical manipulation of the vaginal cuff.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 75, women only
You may be able to join if
- Female patients aged 35-75 years
- Scheduled for total laparoscopic hysterectomy for benign gynecologic conditions, including leiomyoma uteri, adenomyosis, abnormal uterine bleeding...
- American Society of Anesthesiologists (ASA) physical status class I-II
- Cognitive ability sufficient to assess and report postoperative pain (no dementia or severe psychiatric disorder)
- Provision of written informed consent
You likely can't join if
- Presence or suspicion of malignant gynecologic disease
- History of allergy or hypersensitivity to bupivacaine or other amide-type local anesthetics
- History of chronic pain syndrome, analgesic dependence, or regular use of opioids or nonsteroidal anti-inflammatory drugs (NSAIDs)
- Severe systemic disease (e.g., uncontrolled diabetes mellitus, hepatic or renal insufficiency, or heart failure)
- Neurological or psychiatric disorders that impair the ability to assess or report pain
See the full eligibility criteria
- Female patients aged 35-75 years
- Scheduled for total laparoscopic hysterectomy for benign gynecologic conditions, including leiomyoma uteri, adenomyosis, abnormal uterine bleeding, endometrial pathology (non-atypical hyperplasia, endometrial...
- American Society of Anesthesiologists (ASA) physical status class I-II
- Cognitive ability sufficient to assess and report postoperative pain (no dementia or severe psychiatric disorder)
- Provision of written informed consent
- Completion of surgery laparoscopically as planned (no conversion to laparotomy)
- Presence or suspicion of malignant gynecologic disease
- History of allergy or hypersensitivity to bupivacaine or other amide-type local anesthetics
- History of chronic pain syndrome, analgesic dependence, or regular use of opioids or nonsteroidal anti-inflammatory drugs (NSAIDs)
- Severe systemic disease (e.g., uncontrolled diabetes mellitus, hepatic or renal insufficiency, or heart failure)
- Neurological or psychiatric disorders that impair the ability to assess or report pain
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Gaziosmanpaşa, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 35 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Gaziosmanpaşa, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.